Lambert-Eaton myasthenic syndrome. Clinical and electrophysiological findings in seven cases

Electromyography and Clinical Neurophysiology

Volumn 44, Issue 5, 2004, Pages 289-292

  Zambelis, Th ^a   Foutsitzi, A ^a   Giannakopoulou, A ^a   Poulopoulou, K ^a   Karandreas, N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; ANTINEOPLASTIC AGENT; MUSCLE ANTIBODY; PREDNISOLONE; PYRIDOSTIGMINE; VOLTAGE GATED CALCIUM CHANNEL;

ADULT; AGED; ARTICLE; BLADDER CANCER; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DIPLOPIA; DYSARTHRIA; EATON LAMBERT SYNDROME; ELECTROMYOGRAM; HUMAN; IMPOTENCE; LOW DRUG DOSE; LUNG SMALL CELL CANCER; LYMPH NODE BIOPSY; MALE; MUSCLE ACTION POTENTIAL; MUSCLE WEAKNESS; NERVE STIMULATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROENDOCRINE TUMOR; NYSTAGMUS; PTOSIS; REST; TENDON REFLEX; XEROSTOMIA;

ACTION POTENTIALS; ADULT; AGED; CALCIUM CHANNELS; CARCINOMA, SMALL CELL; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; LEUKEMIA, LYMPHOCYTIC; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SKELETAL; URINARY BLADDER NEOPLASMS;

EID: 4444333591     PISSN: 0301150X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. AAEM quality assurance committee. Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle Nerve, 24: 1239-1247, 2001.
2. Burns, T.M., Russell, J.A., Laachance, D.H. and Jones, H.R.: Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome. Ann Neurol, 53: 270-273, 2003.
3. Clouston, P.D., Saper, C.B., Arbizu, T., Johnston, I., Lang, B., Newsom-Davis, J. and Posner, J.B.: Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology, 42: 1944-1950, 1992.
4. Graus, F., Lang, B., Pozo-Rosich, P., Saiz, A., Casamitjana, R. and Vincent, A.: P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology, 59: 764-766, 2002.
5. Lambert, E.H., Eaton, L.M. and Rooke, E.D.: Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol., 187: 612, 1956.
6. Lang, B., Newsom-Davis, J., Wray, D., Vincent, A. and Murray, N.: Autoimmune etiology for myasthenic (Eaton-Lambert) syndrome. Lancet, 2: 224-226, 1981.
7. Lennon, V.A., Kryzer, T.J., Griesmann, G.E., O Suilleabhain, P.E., Windebank, A.J., Woppmann, A. and et al.: Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med., 332: 1467-74, 1995.
8. Maddison, P., Newsom-Davis, J. and Mills, K.R.: Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome. J. Neurol. Neurosurg. Psychiat., 65: 213-217, 1998.
9. Maddison, P., Lang, B., Mills, K. and Newsom-Davis, J.: Long-term outcome in Lambert-Eaton myasthenic syndrome without lung cancer. J. Neurol. Neurosurg. Psychiat., 70: 212-217, 2001.
10. Mason, W.P., Graus, F., Lang, B., Jonnorat, J., Delattre, J.Y., Valdeoriola, F. et al.: Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain, 120: 1279-1300, 1997.
11. Motomura, M., Lang, B., Johnston, I., Palace, J., Vincent, A. and Newsom-Davis, J.: Incidence of serum anti-P/Q type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J. Neurol. Sciences, 147: 35-42, 1997.
12. Nakao, Y.K., Motomura, M., Fukudome, T., Fukuda, T., Shiraishi, H., Yoshimura, T. et al.: Seronegative Lambert-Eaton myasthenic syndrome. Study of 110 Japanese patients. Neurology, 59: 1773-1775, 2002.
13. Newsom-Davis, J.: A treatment algorithm for Lambert-Eaton myasthenic syndrome. Ann N. Y. Acad Sci., 841: 817-822, 1998.
14. Oh, S.J, Kim, D.E., Kuruoglu, R, Brooks, J and Claussen, G.: Electrophysiological and clinical correlations in the Lambert-Eaton myasthenic syndrome. Muscle Nerve, 19: 903-906, 1996.
15. O'Neill, J.H., Murray, N.M. and Newsom-Davis, J.: The Lambert Eaton Myasthenic Syndrome. A review of 50 cases. Brain, 111: 577-596, 1988.
16. O Suilleabhain, P., Low, P.A. and Lennon, V.A.: Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome.Serologic and clinical correlates. Neurology, 50: 88-93, 1998.
17. Prior, C., Lang, B., Wray, D. and Newsom-Davis, J.: Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals. Ann. Neurol., 17: 587-592, 1985.
18. Tim, R.W., Massey, J.M. and Sanders, D.B., Lambert-Eaton myasthenic syndrome: Electrodiagnostic findings and response to treatment. Neurology, 54: 2176-2178, 2000.
19. Wirtz, P.W., Smallegange, T.M., Wintzen, A.R. and Verschuuren, J.J.: Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg, 104: 359-363, 2002.